Skip to main content
. 2015 Feb 3;10(2):e0117741. doi: 10.1371/journal.pone.0117741

Table 3. Intrahepatic HBV total DNA and cccDNA after 48-week entecavir therapy in HBeAg-positive patients.

Items N Baseline Week 48 p
Intrahepatic HBV total DNA 20 3.5×107 4.5×103 < 0.01
(Copies/106 cells, Median, range) (4.8×106~6.7×108) (7.2×102~6.1×104)
Intrahepatic HBV cccDNA 20 1.3×106 3.6×103 < 0.01
(Copies/106 cells, Median, range) (4.5×104~2.1×107) (6.2×102~5.1×104)
Percentage of HBV cccDNA (%) 20 3.4 (0.2–28.4) 85.0 (43.1~96.2) < 0.01